Get started
Author

Bryony Dawkins

Observed names: B Dawkins, B. Dawkins, Bryony R Dawkins, Dawkins, Bryony, Dawkins, Bryony Ruth
Institution: University of Leeds
ORCID: 0000-0002-7038-1975
Observed ORCID: 0000-0002-7038-1975
OpenAlex ID: A5033896752
Using Cost-Effectiveness Analysis to Address Health Equity Concerns
2017 · Richard Cookson, Andrew J. Mirelman, et al. · Value in Health · 327
PDF
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
2021 · Kate Absolom, Lorraine Warrington, et al. · Journal of Clinical Oncology · 307
PDF
What factors affect patients’ ability to access healthcare? An overview of systematic reviews
2021 · Bryony Dawkins, Charlotte Renwick, et al. · Tropical Medicine & International Health · 258
PDF
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
2019 · Mark T Drayson, Stella Bowcock, et al. · The Lancet Oncology · 168
PDF
Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia
2017 · Bryony R Dawkins, Andrew J Mirelman, et al. · Health Policy and Planning · 46
PDF
F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
2022 · Amy Beth Coulson, Kara-Louise Royle, et al. · BMJ Open · 36
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
2018 · Sarah Brown, Colin C Everett, et al. · Health Technology Assessment · 35
PDF
Cost‐effectiveness analysis of a multi‐dimensional intervention to reduce inappropriate antibiotic prescribing for children with upper respiratory tract infections in China
2018 · Zhitong Zhang, Bryony Dawkins, et al. · Tropical Medicine & International Health · 24
PDF
Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs
2022 · Galina Velikova, Kate Absolom, et al. · Programme Grants for Applied Research · 20
PDF
Training programme in gasless laparoscopy for rural surgeons of India (TARGET study) - Observational feasibility study
2021 · N. Aruparayil, J. Gnanaraj, et al. · International Journal of Surgery Open · 19
PDF
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
2022 · Kara-Louise Royle, Amy Beth Coulson, et al. · BMJ Open · 18
PDF
Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa
2019 · Abualbishr Alshreef, Kim MacQuilkan, et al. · Value in Health Regional Issues · 16
PDF
IMWG Frailty Score-Adjusted Therapy Delivery Reduces the Early Mortality Risk in Newly Diagnosed Tne Multiple Myeloma: Results of the UK Myeloma Research Alliance (UK-MRA) Myeloma XIV Fitness Trial
2024 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 15
An intervention to increase physical activity in care home residents: results of a cluster-randomised, controlled feasibility trial (the REACH trial)
2021 · Anne Forster, Jennifer Airlie, et al. · Age and Ageing · 15
PDF
What factors affect patients’ access to healthcare? Protocol for an overview of systematic reviews
2020 · Bryony Dawkins, Charlotte Renwick, et al. · Systematic Reviews · 15
PDF
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results
2022 · Holger W. Auner, Sarah R. Brown, et al. · Blood Cancer Journal · 14
PDF
Fitness, a UK Myeloma Research Alliance (UK-MRA) Frailty-Adjusted Therapy Study, Supports the Feasibility of Recruiting Frail Newly Diagnosed Myeloma Patients to Large Clinical Trials
2021 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 13
Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (FiTNEss): A UK Myeloma Research Alliance Study, Myeloma XIV
2019 · David Cairns, Charlotte Pawlyn, et al. · Blood · 13
Dynamic Frailty Assessment in Transplant Non-Eligible Newly Diagnosed Myeloma Patients: Initial Data from UK Myeloma Research Alliance (UK-MRA) Myeloma XIV (FiTNEss): A Frailty-Adjusted Therapy Study
2023 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 12
Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy
2020 · Alex Molassiotis, Bryony Dawkins, et al. · Acupuncture in Medicine · 11
PDF
Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy
2024 · Bryony Dawkins, Kate Absolom, et al. · JCO Oncology Practice · 9
Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis
2020 · Andrew J. Mirelman, Miqdad Asaria, et al. · World Scientific series in global healthcare economics and public policy · 9
Longer-term health and social care strategies for stroke survivors and their carers: the LoTS2Care research programme including cluster feasibility RCT
2021 · Anne Forster, Seline Ozer, et al. · Programme Grants for Applied Research · 8
PDF
Patient and clinician perspectives of an eHealth intervention for supporting cancer treatment in the UK: mixed methods evaluation of the eRAPID randomised controlled trial
2024 · Lorraine Warrington, Marie Holmes, et al. · BMJ Open · 7
PDF
An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care)
2023 · Anne Forster, Seline Ozer, et al. · Pilot and Feasibility Studies · 7
PDF
Works count: 120
Citation count: 1,481
H-index: 15
I10-index: 20
Year
Topic
Type